Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de estudo
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Clin Biochem ; 50(12): 733-736, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28288851

RESUMO

OBJECTIVES: While copper deficiency has long been known to cause cytopenias, copper deficiency myeloneuropathy is a more recently described entity. Here, we present the case of two clinically distinct presentations of acquired copper deficiency syndromes secondary to excessive use of zinc-containing denture adhesive over five years: myeloneuropathy and severe macrocytic anemia and neutropenia. METHODS: Extensive laboratory testing and histologic evaluation of the liver and bone marrow, were necessary to rule out other disease processes and establish the diagnosis of copper deficiency. RESULTS: The initial presentation consisted of a myelopathy involving the posterior columns. Serum and urine copper were significantly decreased, and serum zinc was elevated. On second presentation (five years later), multiple hematological abnormalities were detected. Serum copper was again decreased, while serum zinc was elevated. CONCLUSIONS: Zinc overload is a preventable cause of copper deficiency syndromes. This rare entity presented herein highlights the importance of patient, as well as provider, education.


Assuntos
Adrenoleucodistrofia/diagnóstico , Anemia Macrocítica/diagnóstico , Cobre/deficiência , Cimentos Dentários/efeitos adversos , Neutropenia/diagnóstico , Zinco/efeitos adversos , Adrenoleucodistrofia/etiologia , Adrenoleucodistrofia/patologia , Adulto , Anemia Macrocítica/etiologia , Anemia Macrocítica/patologia , Dentaduras , Feminino , Humanos , Neutropenia/etiologia , Neutropenia/patologia , Síndrome
2.
Exp Hematol ; 13(7): 652-7, 1985 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-2863163

RESUMO

Cellulose ester membranes (CEM) were implanted intraperitoneally into S1/S1d and S1+/ S1+ mice. These CEM rapidly became coated with peritoneal cells capable of supporting primarily granulocytic colony development after seven days. S1/S1d-coated CEM showed a diminished capacity to support colony development compared with S1+/ S1+ CEM, perhaps reflecting the defect in the hematopoietic microenvironment of these mice. Marrow cells from S1+/S1+ and S1/S1d mice generated similar numbers of colonies on S1+/S1+ CEM. When CEM were transferred from a primary to a secondary host there was a tendency to remodel the CEM toward the characteristics of the secondary host. Peritoneal cells coating CEM from S1/S1d mice had less phagocytosis of yeast particles than peritoneal cells from S1+/S1+ mice. The cell coat on the membranes from S1/S1d mice was fewer cell layers in thickness than those on membranes coated in S1+/ S1+ mice.


Assuntos
Anemia Macrocítica/fisiopatologia , Celulose/análogos & derivados , Granulócitos/patologia , Hematopoese , Membranas Artificiais , Anemia Macrocítica/genética , Anemia Macrocítica/patologia , Animais , Feminino , Hematopoese/efeitos da radiação , Transplante de Células-Tronco Hematopoéticas , Macrófagos/fisiologia , Camundongos , Fagocitose
3.
Exp Toxicol Pathol ; 53(2-3): 97-105, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11484844

RESUMO

2-butoxyethanol (BE; ethylene glycol monobutyl ether) is used extensively in the manufacture of a wide range of domestic and industrial products which may result in human exposure and toxicity. BE causes severe hemolytic anemia in male and female rats and mice. In a recent report, female F344 rats exposed to 500 ppm BE by inhalation and sacrificed moribund on day 4 of treatment exhibited disseminated thrombosis associated with infarction in several organs. In contrast, no such lesions were observed in male rats similarly exposed to BE. Additional studies were therefore undertaken to compare the effects of BE in rats of both sexes. Rats received 250 mg BE/kg/day by gavage for 1, 2 or 3 days and were sacrificed 24 or 48 hr after the last dose. Control rats received 5 ml/kg water. Progressive time-dependent hemolytic anemia--macrocytic, hypochromic, and regenerative--was observed in both sexes of rats exposed to BE. Additionally, BE caused significant morphological changes in erythrocytes, first observed 24 hr after a single dose, including stomatocytosis, macrocytosis with moderate rouleaux formation, and spherocytosis. These morphological changes became progressively more severe as BE dosing continued and included the occasional occurrence of schistocytes and ghost cells, rouleaux formation in rats of both sexes, and an increased number of red blood cells with micronuclei in female rats. Overall, the progression of hemolytic anemia and morphological changes as a function of the number of days of exposure varied with gender and suggested a faster onset of hemolysis in female rats. The range of BE-related histopathological changes noted in both sexes was comparable; however, while these lesions were observed in female rats following a single dose, similar effects were first observed in males after 3 consecutive days of exposure to BE. Pathological changes involved disseminated thrombosis in the lungs, nasal submucosa, eyes, liver, heart, bones and teeth, with evidence of infarction in the heart, eyes, teeth and bones. Hemoglobinuric nephrosis and splenic extramedullary hematopoiesis were also noted. An apparent correlation between the severity of hemolytic anemia and subsequent disseminated thrombosis in BE-treated rats is proposed. Thrombosis may be related to intravascular hemolysis, which could be triggered by procoagulant release and/or alterations in erythrocyte morphology, as well as increased rigidity.


Assuntos
Anemia Hemolítica/induzido quimicamente , Etilenoglicóis/toxicidade , Infarto/induzido quimicamente , Solventes/toxicidade , Trombose/induzido quimicamente , Administração Oral , Anemia Hemolítica/patologia , Anemia Hipocrômica/induzido quimicamente , Anemia Hipocrômica/patologia , Anemia Macrocítica/induzido quimicamente , Anemia Macrocítica/patologia , Animais , Eritrócitos/efeitos dos fármacos , Eritrócitos/patologia , Etilenoglicóis/administração & dosagem , Feminino , Fêmur/efeitos dos fármacos , Fêmur/patologia , Hemólise/efeitos dos fármacos , Infarto/patologia , Masculino , Odontoblastos/efeitos dos fármacos , Odontoblastos/patologia , Ratos , Ratos Endogâmicos F344 , Fatores Sexuais , Solventes/administração & dosagem , Trombose/patologia , Dente/efeitos dos fármacos , Dente/patologia
4.
Br J Haematol ; 50(4): 549-61, 1982 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-6175336

RESUMO

A brother and sister of Pakistani origin suffered from sensorineural deafness, diabetes mellitus and a macrocytic anaemia. Their bone marrows showed megaloblastic erythropoiesis and contained many ringed sideroblasts. Electron microscope studies of the bone marrow revealed (1) iron-laden mitochondria in many erythroblasts, (2) non-specific abnormalities indicative of dyserythropoiesis in some erythroblasts, and (3) evidence of ineffective erythropoiesis. The deoxyuridine suppression test indicated that the megaloblastic changes were not caused by an impairment of the methylation of deoxyuridylate. Studies of nucleic acid synthesis in the bone marrow cells showed that the rate of incorporation of [3H]thymidine into DNA was increased and that the rates of incorporation of [14C]glycine and [14C]adenine into both DNA and RNA were essentially within the normal range. The anaemia did not respond to therapy with hydroxocobalamin, folic acid or pyridoxine but responded to 25 mg thiamine, daily, by mouth. In one of the cases a post-thiamine marrow aspirate showed a considerable improvement in both the megaloblastic and sideroblastic changes.


Assuntos
Anemia Macrocítica/tratamento farmacológico , Tiamina/uso terapêutico , Anemia Macrocítica/genética , Anemia Macrocítica/patologia , Medula Óssea/metabolismo , Medula Óssea/ultraestrutura , Criança , DNA/biossíntese , Surdez/genética , Desoxiuridina/metabolismo , Diabetes Mellitus/genética , Eritroblastos/ultraestrutura , Feminino , Humanos , Masculino , Microscopia Eletrônica , Mitocôndrias/ultraestrutura , Piridoxina/uso terapêutico , RNA/biossíntese
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA